Legislative Guidance and Experiences in Rescheduling Pseudoephedrine
|
Date: Tuesday, February 1, 2011 Downloads
|
Progress has been made in reducing clandestine drug labs through precursor chemical legislation. Two presenters will discuss the challenges in new legislation development, guidance as to how to work effectively with State legislatures, and prior experiences and successes in rescheduling pseudoephedrine in States such as Oregon.
Presenter(s)
Amy Prenda
President - A Prenda Company
Lincoln, Nebraska
Rob Bovett
District Attorney
Lincoln County, Oregon
